Acetylcysteine in IPF: the knockout blow?

Affiliations

¹ Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
² Department of Medicine, University of California San Francisco, San Francisco, CA 94123, USA. Electronic address: Hal.Collard@ucsf.edu.

Comment

Marlies S Wijsenbeek et al. Lancet Respir Med. 2016 Jun.

. 2016 Jun;4(6):420-1.

doi: 10.1016/S2213-2600(16)30085-6. Epub 2016 May 5.

¹ Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
² Department of Medicine, University of California San Francisco, San Francisco, CA 94123, USA. Electronic address: Hal.Collard@ucsf.edu.

No abstract available

Comment on

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C. Behr J, et al. Lancet Respir Med. 2016 Jun;4(6):445-53. doi: 10.1016/S2213-2600(16)30044-3. Epub 2016 May 5. Lancet Respir Med. 2016. PMID: 27161257 Clinical Trial.